Birdwatch Note
2025-05-10 11:37:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The author states, “Saffron had the largest decrease in depressive symptoms.” However, it was saffron PLUS antidepressants (ADT) that had the largest decrease in depressive symptoms. https://www.cambridge.org/core/journals/psychological-medicine/article/comparative-efficacy-and-tolerability-of-nutraceuticals-for-depressive-disorder-a-systematic-review-and-network-metaanalysis/5799A126D0B5677764562824C452D545
Written by B7D03FADC1F8EB21F7A54492DFB2989113566EB15009D369FF33A8EB566DD9CC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1920867165420327294
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1921167613540851784
- noteId - 1921167613540851784
- participantId -
- noteAuthorParticipantId - B7D03FADC1F8EB21F7A54492DFB2989113566EB15009D369FF33A8EB566DD9CC Participant Details
- createdAtMillis - 1746877027293
- tweetId - 1920867165420327294
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The author states, “Saffron had the largest decrease in depressive symptoms.” However, it was saffron PLUS antidepressants (ADT) that had the largest decrease in depressive symptoms. https://www.cambridge.org/core/journals/psychological-medicine/article/comparative-efficacy-and-tolerability-of-nutraceuticals-for-depressive-disorder-a-systematic-review-and-network-metaanalysis/5799A126D0B5677764562824C452D545
Note Ratings
rated at | rated by | |
2025-05-11 17:31:54 -0500 | Rating Details | |
2025-05-11 13:46:20 -0500 | Rating Details | |
2025-05-11 12:50:35 -0500 | Rating Details | |
2025-05-11 12:41:35 -0500 | Rating Details | |
2025-05-11 11:55:56 -0500 | Rating Details | |
2025-05-11 11:38:39 -0500 | Rating Details | |
2025-05-11 02:15:37 -0500 | Rating Details | |
2025-05-10 15:54:58 -0500 | Rating Details | |
2025-05-10 14:42:55 -0500 | Rating Details | |
2025-05-10 14:36:47 -0500 | Rating Details | |
2025-05-10 11:54:09 -0500 | Rating Details | |
2025-05-10 10:40:29 -0500 | Rating Details | |
2025-05-10 10:22:15 -0500 | Rating Details | |
2025-05-10 09:05:56 -0500 | Rating Details | |
2025-05-10 08:03:18 -0500 | Rating Details | |
2025-05-10 07:03:41 -0500 | Rating Details | |
2025-05-10 15:49:25 -0500 | Rating Details | |
2025-05-10 10:53:02 -0500 | Rating Details | |
2025-05-10 10:12:14 -0500 | Rating Details | |
2025-05-12 01:25:59 -0500 | Rating Details | |
2025-05-12 00:37:23 -0500 | Rating Details | |
2025-05-11 17:48:32 -0500 | Rating Details | |
2025-05-11 13:48:16 -0500 | Rating Details | |
2025-05-11 12:04:25 -0500 | Rating Details | |
2025-05-11 11:46:34 -0500 | Rating Details | |
2025-05-11 11:32:26 -0500 | Rating Details | |
2025-05-11 00:04:33 -0500 | Rating Details | |
2025-05-10 20:32:31 -0500 | Rating Details | |
2025-05-10 17:29:07 -0500 | Rating Details | |
2025-05-10 13:08:22 -0500 | Rating Details | |
2025-05-10 11:42:03 -0500 | Rating Details | |
2025-05-10 07:49:12 -0500 | Rating Details | |
2025-05-10 07:31:05 -0500 | Rating Details | |
2025-05-12 06:06:45 -0500 | Rating Details | |
2025-05-11 16:29:39 -0500 | Rating Details | |
2025-05-11 13:01:50 -0500 | Rating Details | |
2025-05-11 12:36:25 -0500 | Rating Details | |
2025-05-11 12:27:08 -0500 | Rating Details | |
2025-05-11 04:16:47 -0500 | Rating Details | |
2025-05-10 17:49:03 -0500 | Rating Details | |
2025-05-10 14:13:36 -0500 | Rating Details | |
2025-05-10 13:57:06 -0500 | Rating Details | |
2025-05-10 13:35:10 -0500 | Rating Details | |
2025-05-10 11:14:47 -0500 | Rating Details | |
2025-05-10 11:03:42 -0500 | Rating Details | |
2025-05-10 10:51:18 -0500 | Rating Details | |
2025-05-10 10:18:04 -0500 | Rating Details | |
2025-05-10 09:58:47 -0500 | Rating Details | |
2025-05-10 08:30:51 -0500 | Rating Details | |
2025-05-11 20:53:16 -0500 | Rating Details | |
2025-05-11 17:58:08 -0500 | Rating Details | |
2025-05-11 14:08:12 -0500 | Rating Details | |
2025-05-11 13:32:03 -0500 | Rating Details | |
2025-05-11 12:55:33 -0500 | Rating Details | |
2025-05-11 11:53:17 -0500 | Rating Details | |
2025-05-11 02:13:10 -0500 | Rating Details | |
2025-05-10 22:24:11 -0500 | Rating Details | |
2025-05-10 11:04:49 -0500 | Rating Details | |
2025-05-10 10:58:38 -0500 | Rating Details | |
2025-05-10 10:19:43 -0500 | Rating Details | |
2025-05-10 09:56:36 -0500 | Rating Details | |
2025-05-10 09:56:07 -0500 | Rating Details | |
2025-05-10 08:34:30 -0500 | Rating Details | |
2025-05-12 13:13:46 -0500 | Rating Details | |
2025-05-11 16:30:59 -0500 | Rating Details | |
2025-05-11 13:51:05 -0500 | Rating Details | |
2025-05-11 11:54:09 -0500 | Rating Details | |
2025-05-11 04:34:33 -0500 | Rating Details | |
2025-05-10 16:48:22 -0500 | Rating Details | |
2025-05-10 12:36:10 -0500 | Rating Details | |
2025-05-10 11:30:23 -0500 | Rating Details | |
2025-05-10 09:36:54 -0500 | Rating Details | |
2025-05-10 08:27:32 -0500 | Rating Details | |
2025-05-10 07:57:45 -0500 | Rating Details | |
2025-05-17 04:11:02 -0500 | Rating Details | |
2025-05-12 19:45:12 -0500 | Rating Details | |
2025-05-11 17:22:44 -0500 | Rating Details | |
2025-05-11 14:42:28 -0500 | Rating Details | |
2025-05-11 14:02:10 -0500 | Rating Details | |
2025-05-11 13:21:06 -0500 | Rating Details | |
2025-05-11 12:29:35 -0500 | Rating Details | |
2025-05-11 11:57:13 -0500 | Rating Details | |
2025-05-11 11:50:13 -0500 | Rating Details | |
2025-05-11 11:46:16 -0500 | Rating Details | |
2025-05-11 02:44:28 -0500 | Rating Details | |
2025-05-10 15:19:43 -0500 | Rating Details | |
2025-05-10 10:09:39 -0500 | Rating Details | |
2025-05-10 08:44:02 -0500 | Rating Details | |
2025-05-10 07:46:19 -0500 | Rating Details | |
2025-05-10 07:45:56 -0500 | Rating Details | |
2025-05-10 07:26:55 -0500 | Rating Details | |
2025-05-10 07:02:51 -0500 | Rating Details | |
2025-05-12 23:04:28 -0500 | Rating Details | |
2025-05-11 13:35:19 -0500 | Rating Details | |
2025-05-11 13:25:40 -0500 | Rating Details | |
2025-05-11 11:52:11 -0500 | Rating Details | |
2025-05-11 11:40:47 -0500 | Rating Details | |
2025-05-10 16:54:58 -0500 | Rating Details | |
2025-05-10 12:02:18 -0500 | Rating Details | |
2025-05-10 11:04:10 -0500 | Rating Details | |
2025-05-10 11:02:15 -0500 | Rating Details | |
2025-05-10 07:22:49 -0500 | Rating Details | |
2025-05-14 16:44:59 -0500 | Rating Details | |
2025-05-12 00:56:42 -0500 | Rating Details | |
2025-05-12 00:43:25 -0500 | Rating Details | |
2025-05-11 21:47:20 -0500 | Rating Details | |
2025-05-11 13:13:22 -0500 | Rating Details | |
2025-05-11 12:17:31 -0500 | Rating Details | |
2025-05-11 11:49:58 -0500 | Rating Details | |
2025-05-11 11:46:42 -0500 | Rating Details | |
2025-05-11 09:45:20 -0500 | Rating Details | |
2025-05-10 12:53:37 -0500 | Rating Details | |
2025-05-10 10:37:55 -0500 | Rating Details | |
2025-05-10 09:36:22 -0500 | Rating Details | |
2025-05-10 09:33:34 -0500 | Rating Details | |
2025-05-10 09:29:34 -0500 | Rating Details | |
2025-05-10 09:08:55 -0500 | Rating Details | |
2025-05-10 08:34:39 -0500 | Rating Details | |
2025-05-10 08:11:26 -0500 | Rating Details | |
2025-05-10 07:40:33 -0500 | Rating Details | |
2025-05-12 07:57:05 -0500 | Rating Details | |
2025-05-11 14:40:41 -0500 | Rating Details | |
2025-05-11 14:21:06 -0500 | Rating Details | |
2025-05-11 13:52:29 -0500 | Rating Details | |
2025-05-11 13:31:07 -0500 | Rating Details | |
2025-05-11 12:42:52 -0500 | Rating Details | |
2025-05-11 04:07:27 -0500 | Rating Details | |
2025-05-10 11:13:42 -0500 | Rating Details | |
2025-05-10 07:23:10 -0500 | Rating Details | |
2025-05-10 11:03:48 -0500 | Rating Details | |
2025-05-10 11:09:30 -0500 | Rating Details | |
2025-05-10 18:28:45 -0500 | Rating Details | |
2025-05-10 11:16:10 -0500 | Rating Details | |
2025-05-11 13:04:15 -0500 | Rating Details | |
2025-05-10 08:26:23 -0500 | Rating Details | |
2025-05-15 10:22:27 -0500 | Rating Details | |
2025-05-12 09:46:41 -0500 | Rating Details | |
2025-05-10 14:04:39 -0500 | Rating Details | |
2025-05-11 12:03:09 -0500 | Rating Details | |
2025-05-11 11:56:08 -0500 | Rating Details | |
2025-05-11 14:37:51 -0500 | Rating Details | |
2025-05-11 12:00:02 -0500 | Rating Details | |
2025-05-11 12:36:02 -0500 | Rating Details | |
2025-05-11 11:46:19 -0500 | Rating Details | |
2025-05-11 12:02:59 -0500 | Rating Details | |
2025-05-11 17:54:00 -0500 | Rating Details | |
2025-05-10 19:42:32 -0500 | Rating Details | |
2025-05-11 14:50:08 -0500 | Rating Details | |
2025-05-11 13:14:51 -0500 | Rating Details | |
2025-05-11 22:53:20 -0500 | Rating Details | |
2025-05-21 14:23:34 -0500 | Rating Details |